Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouse

Area of Science:

• Cardiovascular Research
• Nutritional Science
• Molecular Cardiology

Background:

• Hypercholesterolemia is a known risk factor for hypertrophic cardiomyopathy.
• Limited research exists on dietary interventions for early-stage cardiac hypertrophy linked to dyslipidemia.

Purpose of the Study:

• To investigate the effects of quercetin (QCN) on cardiac hypertrophy in a mouse model of hypercholesterolemia.
• To assess QCN's impact on plasma lipid profiles and myocardial remodeling.

Main Methods:

• Utilized 12-week-old Apo E(-/-) hypercholesterolemic mice and wild-type (WT) controls.
• Administered oral low-dose quercetin (0.1 µmol/kg) for 6 weeks.
• Assessed left ventricular (LV) dimensions, mass, cardiac function, and plasma lipid levels.

Main Results:

• Apo E(-/-) mice exhibited significantly increased LV posterior wall thickness and LV mass compared to WT controls.
• QCN treatment significantly reduced total cholesterol and very low-density lipoprotein in Apo E(-/-) mice.
• QCN administration decreased LV posterior wall thickness and LV mass in hypercholesterolemic mice without affecting WT mice.

Conclusions:

• Dietary quercetin effectively modulates plasma cholesterol levels in hypercholesterolemic mice.
• Quercetin demonstrates potential in preventing maladaptive myocardial remodeling associated with dyslipidemia.
• Polyphenolic compounds like quercetin may serve as therapeutic agents for cholesterol management and cardiac protection.